HalioDx Cambrige Seminar at MassBio

On  10/03/2020

Location:  Cambrige

How Brightplex® IHC multiplex technology can help Pharmas in their immuno-oncology biomarker strategy?

Brightplex® is a customizable solution using chromogenic multiplex IHC and image analysis on a single slide allowing multiple biomarkers phenotyping and quantification within the tumor microenvironnment.

One of the biggest challenges in immunotherapy area is to find accurately which patients will benefit from this new treatment. To help drug developers getting this information, the assessment of biomarkers through clinical research studies represent a key step. 

During this seminar, you will learn about HalioDx innovative Brightplex® platform combined with high level immuno-oncology expertise, providing to biotech and pharma partners a unique solution to get meaningful and actionable data through biomarker testing.

Presented by :

    Jacques Fieschi , VP, R&D of HalioDx

    Naouel El Asri, Director Pharma Services , HalioDx

Date: Tuesday March 10th  2020

Time: 9:00am – 12:00pm ET

Le Méridien Boston Cambridge
Meeting room: Robert R. Taylor Room
Cambridge - MIT
20 Sidney Street, Cambridge, MA 02139 USA

A Continental Breakfast buffet will be served at the beginning of the seminar

Register here

  Back to events list